Table 2.
Antibacterial susceptibility rates of the causative Gram negative bacilli isolated from blood cultures.
| Microorganisms | IMP, % | SAM, % | TZP, % | CTX, % | CAZ, % | CFP, % | CIP, % | AN, % | NN, % | SXT, % |
|---|---|---|---|---|---|---|---|---|---|---|
| Escherichia coli (n = 86) | 100 | 46.2 | 78.3 | 65.1 | NA | NA | 25.0 | 93.5 | 92.8 | 23.8 |
| Klebsiella spp. (n = 28) | 100 | 40.7 | 75.0 | 71.4 | NA | NA | 75.0 | 95.8 | 92.3 | 41.2 |
| Pseudomonas aeruginosa (n = 15) | 73.3 | NA | 86.7 | NA | 86.6 | 85.7 | 86.6 | 92.8 | 100 | NA |
| Acinetobacter baumannii (n = 11) | 9.1 | 20 | 18.2 | 0 | 0 | 0 | 9.1 | 22.2 | 85.7 | 11.1 |
| Stenotrophomonas maltophilia (n = 7) | NA | NA | NA | NA | 42.8 | NA | 85.7 | NA | NA | 100 |
| Enterobacter cloacae (n = 6) | 100 | 16.6 | 50.0 | 83.3 | NA | NA | 50.0 | 100 | NA | 16.6 |
| Burkholderia cepacia (n = 1) | 100 | NA | NA | NA | 100 | NA | 0 | NA | NA | 100 |
IMP, imipenem; SAM, ampicillin/sulbactam; TZP, piperacillin/tazobactam; CTX, cefotaxime; CAZ, ceftazidime; CFP, cefepime; CIP, ciprofloxacin; AN, amikacin; NN, netilmicin; SXT, trimethoprim/sulfamethoxazole; NA, not available.